Insights into the NB.1.8.1 Variant of SARS-CoV-2

Shanmugaraj, Balamurugan; Yadav, Dhanush A; Vetrivel, Gokul; Malla, Ashwini; Ramalingam, Sathishkumar

doi:10.22092/ari.2026.371487.3954

Insights into the NB.1.8.1 Variant of SARS-CoV-2

Articles in Press

Document Type : Mini Review

Authors

¹ Department of Biotechnology, Karpagam Academy of Higher Education, Coimbatore, 641021, Tamil Nadu, India

² Department of Biotechnology, PSG College of Arts and Science, Coimbatore 641014, Tamil Nadu, India

³ Plant Genetic Engineering Laboratory, Department of Biotechnology, Bharathiar University, Coimbatore, 641046, Tamil Nadu, India

10.22092/ari.2026.371487.3954

Abstract

Context: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogenic virus which is responsible for coronavirus disease 2019 (COVID-19) pandemic has caused millions of deaths globally since its first identification in December 2019. Since then, several SARS-CoV-2 variants have been emerged leading to waves of SARS-CoV-2 infections and significantly impacted global health. Despite the availability of effective vaccines and preventive measures, new infections with emerging variants continue to occur with each passing year. Data Acquisition: We conducted a review of relevant articles from Scopus, PubMed, and Google Scholar databases to collect and analyze existing literature on the SARS-CoV-2 and its emerging variants. The data from the collected articles were used to highlight the current state of knowledge on the NB.1.8.1 Variant of SARS-CoV-2. Result: The variants derived from the JN.1 are currently circulating worldwide. NB.1.8.1 is the newly identified variant which was classified as a variant under monitoring by the World Health Organization. The continuous emergence of new viral variants presents a significant challenge to public health and immunization efforts. Currently, there are no reported studies assessing the clinical impact of this variant. However, preliminary studies showed that, this variant exhibit enhanced evasion of neutralizing monoclonal antibodies. Further studies are necessary to evaluate the potential impact of this variant on public health. Conclusion: The development of effective public health strategies aimed at prevention, containment, and long-term management of the disease is critical for the disease control. The challenges posed by the variants like NB.1.8.1 can be addressed by combining updated vaccination strategies, non-pharmaceutical interventions, surveillance, and global coordination. Furthermore, continuous monitoring and understanding of the emerging viral variants is vital for keeping the virus under control.

Keywords